Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,823 signal articles · 172 in last 24h · 123,911 total before filter · latest 1h ago
172last 24h
1196last 7d
200● bullish (7d)
132● bearish (7d)
205publishers
AllMacro208Earnings403M&A101Regulatory21Product10Analyst8
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Bloomberg68d agoneutral
US Retail Sales Rise in Broad Gain Despite Higher Gas Prices

(Bloomberg) -- US consumers ramped up spending in May across a broad range of retailers, signaling households powered ahead despite higher gasoline prices.Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranModi Warns of ‘Shortage of Trust’ Ahead of Trump MeetingIran’s Deputy Foreign Minister Confirms Deal Reached With USNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gains in Peace DealThe value of retail purchases rose 0.

US stocks open higher, spotlight on Fed
Reuters68d agoneutral
US stocks open higher, spotlight on Fed

June 17 (Reuters) - The main U.S. stock indexes opened higher on Wednesday, as chip stocks rebounded ahead of the first interest rate decision under new Federal Reserve Chair Kevin Warsh.

Reuters68d agoneutral
AI startup Genspark valued at $2.6 billion in latest funding round

Technology company Genspark.ai said on Wednesday it had raised $100 million in its extended funding round ‌that valued it at $2.6 billion, underscoring strong investor appetite ‌for AI companies developing workplace productivity tools. The round was backed by existing investors ​including Sozo Ventures, Korea Mirae Asset and UpHonest Capital. The latest investment brings the Palo Alto, California-based company's total Series B financing to $485 million.

Bloomberg68d agoneutral
Snubbing Nvidia for Adobe Costs Florida Stock-Picker $50 Billion

(Bloomberg) -- It was 180 degrees off the hot trade on Wall Street. Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranModi Warns of ‘Shortage of Trust’ Ahead of Trump MeetingIran’s Deputy Foreign Minister Confirms Deal Reached With USNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gains in Peace DealSnub Nvidia Corp., the soaring king of artificial intelligence chips. Embrace Adobe Inc., a sinking casualty of AI disruptio

Treasury Yields Rise Ahead of First Fed Decision Under Warsh
Barrons.com68d agoneutral
Treasury Yields Rise Ahead of First Fed Decision Under Warsh

Treasury yields tick higher ahead of the first interest rate decision under Fed Chairman Kevin Warsh. Rates are expected to remain unchanged. Investors are curious about how Warsh will change the central bank's communications with the public and its forward guidance.

nLIGHT (LASR): Buy, Sell, or Hold Post Q1 Earnings?
StockStory68d agoneutral
nLIGHT (LASR): Buy, Sell, or Hold Post Q1 Earnings?

What a time it’s been for nLIGHT. In the past six months alone, the company’s stock price has increased by a massive 93.7%, reaching $67.13 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Bloomberg68d agoneutral
The Trump Phone Is More Novelty Than Serious Smartphone Contender

(Bloomberg) -- The Trump phone is finally here — sort of — and it bears little resemblance to the original pitch.Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranIran’s Deputy Foreign Minister Confirms Deal Reached With USModi Warns of ‘Shortage of Trust’ Ahead of Trump MeetingNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gains in Peace DealFirst introduced a year ago at Trump Tower by President Donald Trump’s eldest s

Micron Stock Rebounds But Memory-Chip Frenzy Faces a Fed Test
Barrons.com69d agoneutral
Micron Stock Rebounds But Memory-Chip Frenzy Faces a Fed Test

Micron Technology stock was back on the rise early Wednesday as the memory-chip maker looks to resume its relentless rally. Micron was leading the rebound in premarket trading, rising 3.5%, the second-best performer in the Only Intel was climbing more ahead of the open. When there’s nothing happening Micron stock tends to gain.

Reuters69d agoneutral
Jabil raises annual profit forecast amid strong data center demand

Jabil raised its 2026 profit forecast on Wednesday, as the electronic-component maker ‌looks to capitalize on AI-led demand for ‌data centers. A surge in data-center infrastructure spending, driven by strong ​demand for AI computing power, has benefited companies such as Jabil. "AI infrastructure demand remains extremely strong," said CEO Mike Dastoor, adding the company continued to ‌see better-than-expected performance ⁠particularly in its automotive and connected living segment that had earlier been under ⁠pressure.

Big pharma taps UK playbook to pressure Europe on drug prices
Reuters Videos69d agoneutralVIDEO
Big pharma taps UK playbook to pressure Europe on drug prices

<body><p>STORY: Big pharma is receiving pushback from European capitals on drug pricing.&nbsp;</p><p>So they’re turning to a playbook that brought them success in the UK.</p><p>Making threats to pull investment plans to pressure policymakers.&nbsp;</p><p>The industry notched a win when the British government agreed to increase medicine spending as part of a broader deal to avoid U.S.-imposed tariffs.&nbsp;</p><p>The latest nation to face pressure is Germany, which has been debating legislation to tighten spending on medicines.&nbsp;</p><p>A Reuters European Pharma correspondent Maggie Fick said pressure in the last week has ramped up.&nbsp;</p><p>"The CEO of Pfizer wrote a letter to the German chancellor warning that their future investments in the country may be at risk over these proposed changes to pricing laws."</p><p>Meanwhile, AstraZeneca warned that it may not launch new medicines in Germany if these changes go ahead.</p><p>Earlier in June, Eli Lilly announced it would halve a planned $2.7 billion investment, also citing the proposed legislation.&nbsp;</p><p>This bid to cap costs has centered Germany in a broader tussle between drugmakers and European governments that began several months ago.</p><p>That tension has been sharpened by the impact on Europe of U.S. President Donald Trump's pricing push.</p><p>This aims to tie prescription medicine prices in the lucrative U.S. market to ​lower prices elsewhere, including in Europe.</p><p>Major drugmakers have struck deals with the White House to lower drug costs in exchange for tariff exemptions, adding to pressure for increasing prices elsewhere.</p></body>

Car ‘Playgrounds,’ Smartphone Shopping: Inside Carvana’s New-Car Sales Playbook
The Wall Street Journal69d agoneutral
Car ‘Playgrounds,’ Smartphone Shopping: Inside Carvana’s New-Car Sales Playbook

DALLAS— Carvana became famous for its giant “vending machines” that house the used cars it sells online. “We’re not trying to sell cars here,” Tom Taira, Carvana’s president of special projects, told reporters at its recently remodeled Chrysler-Dodge-Jeep-Ram store in Dallas. The store is one of seven new-car dealerships that Carvana has amassed after a buying spree that began in February 2025.